Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 12Tumor of Exocrine Pancreas 1Resectable Pancreatic Carcinoma 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Neoplasm Metastasis 1Locally Advanced Pancreatic Cancer 1Kidney Failure, Chronic 1Gastroparesis 1Cholangiocarcinoma 1Carcinoma, Acinar Cell 1Adenoma, Islet Cell 1

Interventions

Everolimus 5Temozolomide 4sargramostim 2montanide ISA 51 2lutetium Lu 177 dotatate 2incomplete Freund's adjuvant 2Sunitinib 2Specimen Handling 2Sorafenib 2Octreotide 2Magnetic Resonance Spectroscopy 2Leucovorin 2Fluorouracil 2Cytoreduction Surgical Procedures 2Colony-Stimulating Factors 2Bevacizumab 2surufatinib 1recombinant interferon alpha 2b-like protein 1pentetreotide 1pasireotide 1nimotuzumab 1ibrutinib 1ganitumab 1gallium Ga 68 dotatate 1fludarabine phosphate 1cabozantinib 1atezolizumab 1abemaciclib 1Wound Healing 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenoma, Islet Cell × Pancreatectomy × Clear all
NCT02624154 2015-12-08

Pancreatic Neuroendocrine Tumor:Factor of Surgery Influencing Survival

First Affiliated Hospital, Sun Yat-Sen University

Unknown
2 enrolled

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡